Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors Meeting Abstract


Authors: Drilon, A. E.; DuBois, S. G.; Farago, A. F.; Geoerger, B.; Grilley-Olson, J. E.; Hong, D. S.; Sohal, D.; van Tilburg, C. M.; Ziegler, D. S.; Ku, N.; Cox, M. C.; Nanda, S.; Childs, B. H.; Doz, F. P.
Abstract Title: Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 88s
Language: English
ACCESSION: WOS:000487345804389
DOI: 10.1200/JCO.2019.37.15_suppl.2006
PROVIDER: wos
Notes: Meeting Abstract: 2006 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon